Cellenkos, Inc. logo

Cellenkos, Inc.

Cellenkos is an early stage clinical biotechnology company that focuses on umbilical cord blood derived T-regulatory cellular therapies for treating autoimmune diseases and inflammatory disorders.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.cellenkosinc.com
Founded2016
Disease Focus
Development StagePreclinical
STOCK CODENon Listed
Address
5416 Chaucer Drive, TX 77005
Houston
United States
Email
Contact Number
+1 800 217-8247

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]